How to Structure an Alopecia Note for Prior Authorization
Updated on August 17, 2026
How to Structure an Alopecia Note for Prior Authorization
Why First-Pass Denials Really Happen
Most alopecia prior authorization denials are not clinical disagreements. They are formatting failures. The required number is usually already in the chart. The reviewer just cannot find it.
The friction point in community clinics is simple: the traditional medical note does not match the checklist an insurance claims processor works from. The clinical facts are present, but they are spread across a three-paragraph history, so the reviewer flags the packet as incomplete and patient care stalls.
Pro Tip
What Insurance Reviewers Actually Check
Insurance reviewers for severe alopecia areata therapies check two things: an objective baseline showing 50 percent or greater scalp hair loss, and clear evidence that standard therapies have failed or are medically inappropriate.
When a clinic prescribes a systemic JAK inhibitor, the payer processes the request against a rigid set of clinical criteria. Qualitative phrasing does not satisfy them. A note that reads “the patient exhibits extensive patches of hair loss across the scalp” fails review, because reviewers do not approve on a clinical impression. They approve on a formalized Severity of Alopecia Tool (SALT) score, where a score of 50 or higher generally marks the severe range associated with systemic eligibility.
Pro Tip
Put the SALT Score at the Top of the Note
Place the baseline SALT score in its own dedicated section at the very top of the progress note, completely separate from the history of present illness.
That top section needs three items, and nothing else:
- The baseline SALT score, stated clearly as an isolated data point.
- The specific guided protocol used to capture the tracking photography.
- The date of evaluation.
Think of the intake workflow as an open data framework rather than an essay. The reviewer should read the qualifying number before they read a single sentence of narrative.
Pro Tip
Log Prior Treatments Chronologically
After the baseline score, transition directly into a clean chronological log of previous treatments, not a narrative of the patient’s history.
For each therapy, state three things: the specific treatment used (for example, intralesional corticosteroids or topical therapies), the exact duration, and the clear clinical outcome. If a therapy was skipped because of a medical contraindication, state that rationale explicitly, right next to the treatment name.
This is the second half of the reviewer’s checklist: proof that standard therapies failed or were inappropriate. A list answers it faster than a paragraph.
Pro Tip
Why Manual SALT Scoring Fails Under Time Pressure
Manual SALT scoring is sound in theory and impractical in a busy clinic. A SALT score divides the scalp into four weighted regions, the vertex (40 percent), the posterior (24 percent), and each side (18 percent), then asks the clinician to estimate hair loss in each region, multiply by that region’s weight, and add the results. Done by eye, mid-visit, it is slow and error-prone.
Under that time pressure, most clinicians default to the very qualitative notes that insurers reject. The unstructured note is not a knowledge gap. It is a time gap.
Pro Tip
Capture an Objective Baseline with AI-Guided Imaging
AI-guided imaging on a standard smartphone produces an objective, reproducible SALT score at the point of care, which can be pulled straight into the top of the clinical note.
Instead of estimating quadrant sums or handwriting complex math into the EHR, the clinic captures the score in seconds and gives the reviewer a consistent numerical benchmark. An image-derived, clinician-reviewed score is also easier to defend later: it holds up better than a hand estimate, both at first review and in any appeal.
Pro Tip
Plan for the 24-Week Renewal from Day One
Plan for the renewal cycle at the first visit. Many payers grant an initial approval of about 24 weeks and require a follow-up note proving a meaningful clinical response to extend coverage, commonly framed as a defined drop in the SALT score.
If the baseline note is unstructured, proving a relative change in hair density six months later becomes an administrative burden. A standardized initial chart entry gives the practice an undeniable quantitative and photographic foundation, ready for the renewal review, which protects the patient’s continuity of care and saves hours of appeals.
Pro Tip
The Structured Note Is the System
A structured alopecia note is a system, not a style preference. Lead with the SALT score, log prior therapies cleanly, and capture an objective image-based baseline, and the same chart that clears the first authorization also carries the renewal.
That is the difference between routine first-pass approvals and a queue of administrative rework: fewer appeals, faster approvals, and protected continuity of care.
See exactly how to convert your clinic notes into high-approval charts. Book a demo to walk through AI-guided SALT scoring in your workflow.
Sources & Further Reading
- National Alopecia Areata Foundation. FDA-Approved JAK Inhibitors and Understanding Insurance Coverage and Managing Treatment Access. https://www.naaf.org/navigation-toolkit/fda-approved-jak-inhibitors/
- AJMC. Beyond the SALT Score: Evaluating Alopecia Areata More Holistically. https://www.ajmc.com/view/beyond-the-salt-score-evaluating-alopecia-areata-more-holistically
- Severity of Alopecia Tool (SALT) score methodology and region weighting (Olsen & Hordinsky). SALT score calculation overview. https://dermatopics.dk/salt-score/
The Self-Driving Handoff: Why “The Doctor Will Catch It” Is Healthcare’s Most Dangerous Assumption
